Jci_page_head_homepage_01 Jci_page_head_homepage_02
Kiyoshi Sakai, Akihito Yamamoto, Kohki Matsubara, Shoko Nakamura, Mami Naruse, Mari Yamagata, Kazuma Sakamoto, Ryoji Tauchi, Norimitsu Wakao, Shiro Imagama, Hideharu Hibi, Kenji Kadomatsu, Naoki Ishiguro, Minoru Ueda
Published in Volume 122, Issue 1
J Clin Invest. 2012; 122(1):80–90 doi:10.1172/JCI59251
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Jci59251
Figure 8
SHEDs suppress the apoptosis of neural cell lineages and secondary injury after SCI.

Representative images (AL) and quantifications (M and N) of apoptotic cell death 24 hours after SCI. Transverse sections 1 mm caudal to the epicenter of PBS-injected (A, B, E, F, I, and J) and SHED-transplanted SCs (C, D, G, H, K, and L) were stained with TUNEL and then subjected to immunohistochemical analysis with an anti-GFAP mAb (AD), anti-NeuN mAb (EH), or anti-MBP mAb (IL). The engrafted SHEDs decreased the apoptotic cell death of all 3 neural cell lineages. (M) Quantification of the total TUNEL-positive cell number within 3 mm rostral and caudal to the epicenter shows the average of 3 experiments performed in parallel. (N) The percentage of TUNEL-positive relative to total DAPI-positive cell number in the same area as in M. Error bars represent SD. *P < 0.01 compared with SCI models injected with PBS. Scale bar: 20 μm (L).